---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-002198"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T04:29:10.676713+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cyclacel corrects board appointment error in Securities Purchase Agreement with David Lazar

## Summary
- Addendum corrects inadvertent error: Mr. Lazar was not appointed as Board member or Chairman, only has right to appoint one director.
- David Natan appointed as designee of Lazar and chairman of audit committee.
- Amendment restates Section 2.3(a)(v) to reflect correct intent regarding board appointment and resolutions.
- All other terms of the Purchase Agreement remain unchanged and in full force and effect.

## SEC filing metadata
- accession: 0001104659-25-002198
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465925002198/0001104659-25-002198-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465925002198/tm252869d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-002198
- JSON: https://secwatch.observer/filing/0001104659-25-002198.json
- Plain text: https://secwatch.observer/filing/0001104659-25-002198.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.